PDF herunterladen
Open Access
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2017; 38(02): 190-197
DOI: 10.4103/ijmpo.ijmpo_174_16
Review Article

Cytotoxic Drug Dispersal, Cytotoxic Safety, and Cytotoxic Waste Management: Practices and Proposed India‑specific Guidelines

Authors

  • Malini R Capoor

    Department of Microbiology, VMMC and Safdarjung Hospital, New Delhi, India

  • Kumar Tapas Bhowmik

    Department of Radiotherapy, Biomedical Waste Unit, VMMC and Safdarjung Hospital, New Delhi, India

Financial support and sponsorship Nil.
Weitere Informationen
Auch verfügbar auf
 als PDF herunterladen Lizenzen und Reprints
Preview

Abstract

This article deals with practices related to cytotoxic drug dispersal, cytotoxic safety, and cytotoxic waste management and attempts at India-specific guidelines for their dispersal and disposal. The articles related to cytotoxic drug dispersal, cytotoxic safety, and cytotoxic waste management were reviewed from PubMed and their applicability in Indian health-care facilities (HCFs) was also reviewed. All HCFs dealing with cytotoxic drugs should consider cytotoxic policy, patient safety and health-care worker safety, and environmental monitoring program as per the available international guidelines customized as per Indian conditions. Utmost care in handling cytotoxic waste is quintessential. The formation of India-specific cytotoxic guidelines requires the inputs from all stakeholders. Cytotoxic waste, cytotoxic safety, and cytotoxic waste management should be the subject of a national strategy with an infrastructure, cradle-to-grave legislation, competent regulatory authority, and trained personnel.

Keywords

Cytotoxic drug dispersal - cytotoxic safety - cytotoxic waste


Publikationsverlauf

Artikel online veröffentlicht:
06. Juli 2021

© 2017. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Chartier Y, Emmanuel J, Pieper U, Prüss A, Rushbrook P, Stringer R, et al., editors. Safe Management of Wastes from Health-Care Activities' WHO Blue Book. 2nd ed. Malta: World Health Organization; 2014.
  • 2 NIOSH Publications. Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings. Publication Number 2004-165. Cincinnati, OH: NIOSH Publications; 2004. Available from: http://www.cdc.gov/niosh. [Last assessed on 2017 Apr 25].
  • 3 Cytotoxic Drugs and Their Waste: Risk Management Guide for South Australian Health Services; 2015. Available from: http://www.sahealth.sa.gov.su. [Last assessed on 2017 Apr 25].
  • 4 IARC (International Agency for Research on Cancer). Laboratory Decontamination and Destruction of Carcinogens in Laboratory Waste: Some Hydrazines. IARC Scientific Publications No. 54. Lyon: International Agency for Research on Cancer; 1983.
  • 5 IARC. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. List of IARC Evaluations. Lyon: International Agency for Research on Cancer; 1994.
  • 6 IARC. Laboratory Decontamination and Destruction of Carcinogens in Laboratory Waste: Some Antineoplastic Agents. IARC Scientific Publications No. 73. Lyon: International Agency for Research on Cancer; 1985.
  • 7 Hansel S, Castegnaro M, Sportouch MH, De Méo M, Milhavet JC, Laget M, et al. Chemical degradation of wastes of antineoplastic agents: Cyclophosphamide, ifosfamide and melphalan. Int Arch Occup Environ Health 1997;69:109-14.
  • 8 Castegnaro M, De Méo M, Laget M, Michelon J, Garren L, Sportouch MH, et al. Chemical degradation of wastes of antineoplastic agents 2: Six anthracyclines: Idarubicin, doxorubicin, epirubicin, pirarubicin, aclarubicin, and daunorubicin. Int Arch Occup Environ Health 1997;70:378-84.
  • 9 Easty AC, Coakley N, Cheng R, Cividino M, Savage P, Tozer R, et al. Safe handling of cytotoxics: Guideline recommendations. Curr Oncol 2015;22:e27-37.
  • 10 United States, Department of Health and Human Services, Centers for Disease Control and Prevention (CDC), National Institute for Occupational Health & Safety. Workplace Safety and Health Topics: Engineering Controls. Atlanta, GA: CDC; 2014. Available from: http://www.cdc.gov/niosh/topics/engcontrols/. [Last cited on 2014 May 08].
  • 11 Service Ontario, e-Laws. Occupational Health and Safety Act. Ontario Regulation 67/93: Health Care and Residential Facilities. Toronto, ON: Government of Ontario; 2013. Available from: http://www.e-laws.gov.on.ca/html/regs/english/elaws_regs_930067_e.htm. [Last cited on 2014 May 08].
  • 12 Bio-Medical Waste Management Rules, 2016. Published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (i), Government of India Ministry of Environment, Forest and Climate Change. Notification; New Delhi; the 28t h March, 2016.
  • 13 Service Ontario, e-Laws. Occupational Health and Safety Act. RSO 1990, Ch. 1. Toronto, ON: Government of Ontario; 2011. Available from: http://www.elaws.gov.on.ca/html/statutes/english/elaws_statutes_90o01_e.htm. [Last cited on 2013 Jul 31].
  • 14 ASTM International. ASTM D6978-05: Standard Practice for Assessment of Resistance of Medical Gloves to Permeation by Chemotherapy Drugs. West Conshohocken, PA: ASTM International; 2013.
  • 15 Ontario Agency for Health Protection and Promotion, Provincial Infectious Diseases Advisory Committee. Routine Practices and Additional Precautions. 3rd ed. Toronto, ON: Queen's Printer for Ontario; 2012. Available from: http://www.publichealthontario.ca/en/eRepository/RPAP_All_HealthCare_Settings_Eng2012.pdf. [Last cited on 2014 May 08].
  • 16 ASTM International. ASTM F739-12 Standard Test Method for Permeation of Liquids and Gases through Protective Clothing Materials under Conditions of Continuous Contact. West Conshohocken, PA: ASTM International; 2012. p. 13.
  • 17 Accreditation Canada. Medication Management Standards: For Surveys Starting After: January 01. Ver. 8. Ottawa, ON: Accreditation Canada; 2013.
  • 18 CSA Group. Canadian Health Care Facilities. CSA Z8000-11. Toronto, ON: CSA Group; 2011.
  • 19 Public Health Agency of Canada (PHAC). Laboratory Biosafety Guidelines. 3rd ed. Ottawa, ON: PHAC; 2004.
  • 20 Service Ontario, e-Laws. Occupational Health and Safety Act. Ontario Regulation 474/07: Needle Safety. Toronto, ON: Government of Ontario; 2010. Available from: http://www.e-laws.gov.on.ca/html/regs/english/elaws_regs_070474_e.htm. [Last cited on 2013 Jul 31].
  • 21 Ontario, Ministry of the Environment. Guideline C-4: The Management of Biomedical Waste in Ontario. Toronto, ON: Government of Ontario; 2009. Available from: https://www.dr6j45jk9xcmk.cloudfront.net/documents/1761/197-bio medical-waste-en.pdf. [Last cited on 2013 Jul 30].
  • 22 Transport Canada. Transportation of Dangerous Goods. Ottawa, ON: Transport Canada; 2014. Acts and Regulations can be Searched. Available from: http://www.tc.gc.ca/eng/tdg/safety-menu.htm. [Last cited 2014 May 08].
  • 23 International Society of Oncology Pharmacy Practicioners Standards Committee. ISOPP standards of practice. Safe handling of cytotoxics. J Oncol Pharm Pract 2007;13 (Suppl 1):1-81.
  • 24 Roos I, Makela T. Human resource issues in cytotoxic drug dispensing. J Oncol Pharm Pract 1997;3:200-18.
  • 25 Canadian Association of Pharmacy in Oncology (CAPHO). Standards of Practice for Oncology Pharmacy in Canada. Ver. 2. North Vancouver, BC: CAPHO; 2009.
  • 26 NSF International. Biosafety Cabinetry: Design, Construction, Performance, and Field Certification. NSF/ANSI 49-2008. Ann Arbor, MI: NSF International; 2008. Available from: http://www.standards.nsf.org/apps/group_public/download.php/3604/NSF_49–08e-rep-watermarked.pdf. [Last cited on 2014 May 08].
  • 27 Lawson CC, Rocheleau CM, Whelan EA, Lividoti Hibert EN, Grajewski B, Spiegelman D, et al. Occupational exposures among nurses and risk of spontaneous abortion. Am J Obstet Gynecol 2012;206:327.e1-8.